Portfolio company
Genomic Prediction
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops genetic screening tests for IVF embryos to assess disease risks for fertility clinics and prospective parents.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
Orchid
This company provides whole-genome sequencing and genetic testing services for embryos to prospective parents undergoing fertility treatment.
Reticular
This company develops interpretable artificial intelligence models for embryo genetic screening and drug discovery to assist prospective parents and pharmaceutical researchers.
Future Fertility
This company develops artificial intelligence software for oocyte quality assessment to assist fertility clinics and patients with reproductive treatment decisions.
Imvitro
Imvitro develops an artificial intelligence platform for embryo selection to help fertility clinics improve success rates and transparency for IVF patients.
GenomicMD
This laboratory provides polygenic risk score assessments to help physicians identify patients at increased risk for developing common diseases.
Single molecule diagnostics
This company develops prenatal screening and oncology liquid biopsy tests for clinicians to identify genetic risks and monitor cancer treatments in patients.
3X Genetics
This company develops long-read genetic testing technology and diagnostics for biopharma companies to identify patients with rare repeat expansion disorders.
Orbit Genomics
This company develops AI-powered genomic tests for healthcare providers and patients to diagnose lung cancer and evaluate risks for chronic diseases.
